Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.19

+0.15 (0.26%)

as of Jun 26, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 27, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

DON'T BUY

Increasing hedging to reduce quarterly earnings fluctuations in the equity market and is the reason for the volatility. Owns their fixed income instruments instead, which are safer. Globally, insurers are quite cheap now because of investors concerns on real estate holdings. Would prefer Power Financial (PWF-T), which owns Great West Life (GWO-T).

BUY

Likes it and likes the Asian growth side. They are going to raise the dividend at some stage, perhaps latter half of 2012.

TOP PICK

4.079% Aug 20, 2014 bonds. 3.5% yield currently. Senior debt. Short compared to others.

DON'T BUY

Life insurance companies are supposed to be defensive but this one missed the boat entirely. They then took the hedges off at the bottom of the market. Not going to go down anywhere, it’s just kind of dead.

BUY

Last correction was a higher low so he thinks it goes up. In a nice congestive period currently.

HOLD

Struggled over last couple of years but are getting act together recently. With hedging program in place they are little less prone to ups and down in the market. Bought more recently. Good valuation. Nothing is going happen here soon. In 3-5 years they will turn things around. Growth is in China.

TOP PICK

Pretty much carrying out the plan that Don Guloien laid out for them a couple of years ago. Have de-risked. Last quarter was good. Over time they will get back to the 12%-14% ROE.

PAST TOP PICK

Manulife down since May 28 2010(recommended at $17.58 now at $17.16, Total return 0.91% increase), earnings were solid until last quarter, this is a work through story which will probably take a year or two to play itself out.He thinks it will be worth more but not sure when.

BUY

Market gave it a very high multiple when it was doing crazy things and now everyone hates it when it is doing all the right things. Very cheap multiple and are solving a lot of their issues. Have some really great growth aspects, not only in the US but also in Asia where they are dedicating more capital.

BUY

Just reported and beat their earnings by a large margin. Should continue to do well.

TOP PICK

They have probably passed the bottom. They are now about a third Asia, which is growing quite quickly. They are at the end of 2012 target and balance sheet is way above what is regulated. Have enough capital to raise dividend but they will wait.

BUY

Very good way of playing both the stock market and interest rates. One of the few ways to make money if interest rates rise. Also a positive leverage to the stock market with their variable annuities.

BUY

Is a long-term sufferer on this name. He likes to buy sticks when people hate the names. People don’t understand what’s going on with MFC. Earnings could reach $2-$2.50 normalized in 2-3 years. Trading near book value. Actively putting new clients into it.

BUY

Thinks it’s time to get back in. They’re getting their act together again. Looking attractive. Great international exposure. Thinks it could be earning $2.50-$3 a share in 2 to 3 years without a lot of problem. With a 12 multiple, you are looking at a $30 plus stock along with a dividend.

COMMENT

On his watch list. Two major factors will impact this stock. As interest rates go up, the company will do much better as it will help their bottom line. Market movement t will also affect them. Too expensive for him at this point.

Showing 1,306 to 1,320 of 2,281 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Andrey Omelchak

LionGuard Capital Management

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)